BR9915951A - Processo para preparação de uma composição farmacêutica para uso como um medicamento antiarritmias com um bloqueio beta adrenérgico controlado, composição farmacêutica, preparação oral e parenteral para tratamento de doenças cardìacas em mamìferos, e, método de tratamento para as mesmas - Google Patents
Processo para preparação de uma composição farmacêutica para uso como um medicamento antiarritmias com um bloqueio beta adrenérgico controlado, composição farmacêutica, preparação oral e parenteral para tratamento de doenças cardìacas em mamìferos, e, método de tratamento para as mesmasInfo
- Publication number
- BR9915951A BR9915951A BR9915951-1A BR9915951A BR9915951A BR 9915951 A BR9915951 A BR 9915951A BR 9915951 A BR9915951 A BR 9915951A BR 9915951 A BR9915951 A BR 9915951A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- pharmaceutical composition
- mammals
- oral
- heart disease
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 208000019622 heart disease Diseases 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title abstract 2
- 230000003288 anthiarrhythmic effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 2
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 2
- 241000282414 Homo sapiens Species 0.000 abstract 1
- 230000001800 adrenalinergic effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- ZBMZVLHSJCTVON-UHFFFAOYSA-N sotalol Chemical compound CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1 ZBMZVLHSJCTVON-UHFFFAOYSA-N 0.000 abstract 1
- 229960002370 sotalol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN89KO1999 IN188162B (enExample) | 1999-02-05 | 1999-02-05 | |
| PCT/IB1999/000322 WO2000045807A1 (en) | 1999-02-05 | 1999-02-22 | Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9915951A true BR9915951A (pt) | 2001-08-21 |
Family
ID=38668683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9915951-1A BR9915951A (pt) | 1999-02-05 | 1999-02-22 | Processo para preparação de uma composição farmacêutica para uso como um medicamento antiarritmias com um bloqueio beta adrenérgico controlado, composição farmacêutica, preparação oral e parenteral para tratamento de doenças cardìacas em mamìferos, e, método de tratamento para as mesmas |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6281246B2 (enExample) |
| EP (1) | EP1146865B9 (enExample) |
| JP (1) | JP2002536324A (enExample) |
| CN (1) | CN1149987C (enExample) |
| AT (1) | ATE241349T1 (enExample) |
| AU (1) | AU761521C (enExample) |
| BR (1) | BR9915951A (enExample) |
| CA (1) | CA2348882C (enExample) |
| CZ (1) | CZ20011807A3 (enExample) |
| DE (1) | DE69908421T2 (enExample) |
| DK (1) | DK1146865T3 (enExample) |
| ES (1) | ES2195538T3 (enExample) |
| HK (1) | HK1041206B (enExample) |
| HU (1) | HU224033B1 (enExample) |
| IN (1) | IN188162B (enExample) |
| PL (1) | PL351143A1 (enExample) |
| PT (1) | PT1146865E (enExample) |
| RU (1) | RU2213560C2 (enExample) |
| SE (1) | SE1146865T5 (enExample) |
| WO (1) | WO2000045807A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060105044A1 (en) | 2004-05-20 | 2006-05-18 | Singh Bramah N | Sustained release formulations of sotalol |
| RS53007B (sr) * | 2006-05-18 | 2014-04-30 | Dompe' S.P.A. | (2r)-2-[(4-sulfonil)aminofenil]propanamidi i farmaceutske kompozicije koje ih sadrže |
| CN102329254B (zh) * | 2010-07-12 | 2014-02-05 | 上海奥博生物医药技术有限公司 | 一种制备n-[4-[1-羟基-2-[(1-甲基乙基)胺基]乙基]甲磺酰胺盐酸盐的方法 |
| BE1021328B1 (fr) * | 2014-08-27 | 2015-10-30 | Hyloris Pharmaceuticals SA | Composition pharmaceutique prete a l'emploi |
| BE1021320B1 (fr) * | 2014-08-27 | 2015-10-29 | Hyloris Pharmaceuticals SA | Composition pharmaceutique prete a l'emploi |
| FR3050297A1 (fr) * | 2016-04-13 | 2017-10-20 | Assist Publique - Hopitaux De Paris | Methode de determination de la susceptibilite d'induction d'une torsade de pointes |
| CN109419779B (zh) * | 2017-09-04 | 2021-05-25 | 鲁南制药集团股份有限公司 | 一种盐酸索他洛尔制剂 |
| CN109419780B (zh) * | 2017-09-04 | 2021-05-11 | 张家港市中医医院 | 一种盐酸索他洛尔片剂及其制备方法 |
| CN108785268B (zh) * | 2018-01-17 | 2021-05-28 | 威海华新药业集团有限公司 | 一种盐酸索他洛尔制剂及其制备方法 |
| US10799138B2 (en) | 2018-04-05 | 2020-10-13 | University Of Maryland, Baltimore | Method of administering sotalol IV/switch |
| US12396970B2 (en) | 2021-08-20 | 2025-08-26 | AltaThera Pharmaceuticals LLC | Anti-arrhythmic compositions and methods |
| US11696902B2 (en) | 2018-08-14 | 2023-07-11 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US11344518B2 (en) | 2018-08-14 | 2022-05-31 | AltaThera Pharmaceuticals LLC | Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame |
| US10512620B1 (en) | 2018-08-14 | 2019-12-24 | AltaThera Pharmaceuticals, LLC | Method of initiating and escalating sotalol hydrochloride dosing |
| US11610660B1 (en) | 2021-08-20 | 2023-03-21 | AltaThera Pharmaceuticals LLC | Antiarrhythmic drug dosing methods, medical devices, and systems |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5089526A (en) * | 1983-05-23 | 1992-02-18 | Bristol-Myers Company | Antiarrhythmic class III process |
| JPH01165569A (ja) * | 1987-12-22 | 1989-06-29 | Mitsui Toatsu Chem Inc | 光学活性なソタロールの製造方法 |
| IES61567B2 (en) * | 1994-02-17 | 1994-11-16 | Russinsky Ltd | Pharmaceutical products |
-
1999
- 1999-02-05 IN IN89KO1999 patent/IN188162B/en unknown
- 1999-02-22 PT PT99902781T patent/PT1146865E/pt unknown
- 1999-02-22 SE SE99902781T patent/SE1146865T5/xx unknown
- 1999-02-22 JP JP2000596927A patent/JP2002536324A/ja active Pending
- 1999-02-22 HU HU0104175A patent/HU224033B1/hu active IP Right Grant
- 1999-02-22 EP EP99902781A patent/EP1146865B9/en not_active Expired - Lifetime
- 1999-02-22 BR BR9915951-1A patent/BR9915951A/pt not_active IP Right Cessation
- 1999-02-22 AU AU22960/99A patent/AU761521C/en not_active Ceased
- 1999-02-22 ES ES99902781T patent/ES2195538T3/es not_active Expired - Lifetime
- 1999-02-22 HK HK02102291.0A patent/HK1041206B/en not_active IP Right Cessation
- 1999-02-22 DK DK99902781T patent/DK1146865T3/da active
- 1999-02-22 CN CNB998136395A patent/CN1149987C/zh not_active Expired - Fee Related
- 1999-02-22 DE DE69908421T patent/DE69908421T2/de not_active Expired - Fee Related
- 1999-02-22 WO PCT/IB1999/000322 patent/WO2000045807A1/en not_active Ceased
- 1999-02-22 CA CA002348882A patent/CA2348882C/en not_active Expired - Fee Related
- 1999-02-22 AT AT99902781T patent/ATE241349T1/de not_active IP Right Cessation
- 1999-02-22 CZ CZ20011807A patent/CZ20011807A3/cs unknown
- 1999-02-22 RU RU2001111808/14A patent/RU2213560C2/ru not_active IP Right Cessation
- 1999-02-22 PL PL99351143A patent/PL351143A1/xx not_active IP Right Cessation
-
2000
- 2000-12-19 US US09/739,276 patent/US6281246B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002536324A (ja) | 2002-10-29 |
| PT1146865E (pt) | 2003-08-29 |
| ATE241349T1 (de) | 2003-06-15 |
| EP1146865B1 (en) | 2003-05-28 |
| RU2213560C2 (ru) | 2003-10-10 |
| SE1146865T5 (enExample) | 2003-11-18 |
| US20010004643A1 (en) | 2001-06-21 |
| HUP0104175A3 (en) | 2002-12-28 |
| CZ20011807A3 (cs) | 2001-08-15 |
| DE69908421D1 (de) | 2003-07-03 |
| EP1146865B9 (en) | 2004-03-17 |
| HU224033B1 (hu) | 2005-05-30 |
| CN1149987C (zh) | 2004-05-19 |
| EP1146865A1 (en) | 2001-10-24 |
| ES2195538T3 (es) | 2003-12-01 |
| WO2000045807A1 (en) | 2000-08-10 |
| PL351143A1 (en) | 2003-03-24 |
| DE69908421T2 (de) | 2004-03-18 |
| CA2348882C (en) | 2004-07-13 |
| CN1328453A (zh) | 2001-12-26 |
| US6281246B2 (en) | 2001-08-28 |
| AU761521C (en) | 2004-01-22 |
| AU761521B2 (en) | 2003-06-05 |
| SE1146865T3 (enExample) | 2003-09-02 |
| HK1041206B (en) | 2003-10-31 |
| DK1146865T3 (da) | 2003-09-22 |
| IN188162B (enExample) | 2002-08-31 |
| AU2296099A (en) | 2000-08-25 |
| CA2348882A1 (en) | 2000-08-10 |
| HK1041206A1 (en) | 2002-07-05 |
| HUP0104175A2 (hu) | 2002-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tartara et al. | Vigabatrin in the treatment of epilepsy: a double‐blind, placebo‐controlled study | |
| BR9813373A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente | |
| ES2072323T3 (es) | Compuestos de piperidina y su preparacion y empleo. | |
| BR0209658A (pt) | Derivados de 4-amino-5-fenil-7-1ciclobutil-pirrolo [2,3-d] pirimidina | |
| AU645023B2 (en) | Compositions and method for treating painful, inflammatory or allergic disorders | |
| ES2162615T3 (es) | Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina. | |
| BR0112661A (pt) | Nova combinação de agonista (5ht2) e antagonista (5ht6) da serotonina como formulação farmacêutica | |
| ATE219363T1 (de) | Lösliche prodrugs von paclitaxel | |
| BRPI9708566A (pt) | Análogo de glp-2, análogo de peptìdeo glp-humano, peptìdeo, composição farmacêutica, uso de um análogo de glp-2, e, processo para identificar análogos intestinotróficos de glp-2. | |
| ATE267798T1 (de) | Kombinierte wirkstoffe als methode zur gezielten wirkstoff-freisetzung | |
| ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
| BR0012136A (pt) | Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos | |
| BRPI0410786A (pt) | composição, uso da mesma, e, método de tratamento de um distúrbio de humor em um paciente | |
| BR0015974A (pt) | Uso de levetiracetam, composição farmacêutica, uso de uma composição farmacêutica e métodos para tratar um paciente admintstrado com uma quantidade de pelo menos um composto e uma doença e para potenciar seletivamente o efeito terapêutico de um composto | |
| FR2724384B1 (fr) | Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament | |
| BRPI0411503A (pt) | composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto | |
| BG96513A (bg) | Заместени 4-фенил-4-пиперидинкарбоксамиди с локален обезболяващ и болкоуспокояващ ефект и метод за тяхното получаване | |
| BR9810773A (pt) | Uso de um ingrediente anestésico local de ação prolongada, composição farmacêutica, uso de um anestésico local, e, kit | |
| ES2061727T3 (es) | Sustancias fisiologicamente activas, un procedimiento para su preparacion y composiciones farmaceuticas que las contienen. | |
| BR9908510A (pt) | Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana | |
| CA2348882A1 (en) | Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol | |
| BRPI0410654A (pt) | composto, composição farmacêutica, uso de um composto, método para tratar um distúrbio de um paciente, e, processo para a preparação de um composto | |
| EP0578620B1 (en) | Pharmaceutical compositions for transdermal delivery of melatonin and/or its analogues | |
| US6979441B2 (en) | Method for topical treatment of carpal tunnel syndrome | |
| KR930019224A (ko) | 유산 위험 치료제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DA(S) 9A E 10A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 1986 DE 27/03/2009. |